Kyntra Bio, Inc. (NASDAQ:KYNB) Q4 2025 Earnings Call Transcript March 16, 2026 Kyntra Bio, Inc. beats earnings expectations. Reported EPS is $-3.61, expectations were $-3.885. Operator: Thank you for ...
Q4 FY2025 earnings call recap: 9% sales growth, 5% comps, multi-price expansion, margin outlook and 2026 guidance—read key takeaways now.
13h
Veradermics, Incorporated (MANE) Presents at Leerink Global Healthcare Conference 2026 Transcript
Marc Goodman Leerink Partners LLC, Research Division. Okay. We're going to get going on our next session. Thanks for joining us. I'm Marc Goodman, one of the biopharma analyst at ...
Whistleblowers say Meta and TikTok amplified harmful content and sidelined safety concerns to boost engagement and protect business interests.
How Yahoo escaped its Verizon death spiral and became profitable again.
KinderCare Learning Companies, Inc. which accounted for 88% of our total revenue, continues to be the core driver of our overall performance. Our top quintile centers felt some of the headwinds during ...
Each forward-looking statement is subject to risks and uncertainties that could cause actual results and events to differ materially from those projected in that statement. A more complete description ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results